Monica Gamez
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease.
Journal: Clinical and translational medicine
Published: January 30, 2026
The glomerular endothelial glycocalyx as a therapeutic target in proteinuric kidney disease.
Journal: Nature reviews. Nephrology
Published: October 22, 2025
Podocyte-directed VEGFC gene therapy prevents increased glomerular permeability and glycocalyx damage in experimental type 1 diabetes.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 14, 2025
Endothelial-erythrocyte glycocalyx exchange enables liquid biopsies of endothelial function.
Journal: Nature communications
Published: March 03, 2025
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Journal: Cardiovascular diabetology
Published: February 20, 2024
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Journal: Cardiovascular diabetology
Published: November 12, 2023
Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes.
Journal: Diabetes
Published: June 09, 2023
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
Journal: Clinical science (London, England : 1979)
Published: July 16, 2021
Beta Human Papillomavirus 8E6 Attenuates Non-Homologous End Joining by Hindering DNA-PKcs Activity.
Journal: Cancers
Published: July 19, 2020
Endothelial glycocalyx restoration by growth factors in diabetic nephropathy.
Journal: Biorheology
Published: June 04, 2019
Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease.
Journal: Kidney international
Published: November 05, 2018
Last Updated: 09/26/2026